Lasse Paludan Bentsen
@lpbentsen.bsky.social
MD, PhD-Fellow in Emergency Medicine | Research | Simulation | Critical Care | Emergency Medicine | PHEM | Shock | Fluid Therapy | Team Leadership | POCUS
Coordinating Investigator for the #VASOSHOCK trial.
Coordinating Investigator for the #VASOSHOCK trial.
We just included our 80th patient (of 320) in #VASOSHOCK a multi-center RCT comparing noradrenaline to standard care (Where noradrenaline is not available as an ED intervention) in patients with hypotension and shock.
#emergencymedicine #criticalcare #research
#emergencymedicine #criticalcare #research
Time to celebrate!
Lasse P Bentsen has reached the first 80 (out of 320) patients in his #VasoShock trial.
#VasoShock is an RCT comparing early noradrenalin in the ED in hypotensive patients vs. standard care.
Huge congratulations!
#emergencymedicine #research
www.linkedin.com/posts/lasse-...
Lasse P Bentsen has reached the first 80 (out of 320) patients in his #VasoShock trial.
#VasoShock is an RCT comparing early noradrenalin in the ED in hypotensive patients vs. standard care.
Huge congratulations!
#emergencymedicine #research
www.linkedin.com/posts/lasse-...
#fam #akutmedicin #emergencymedicine #vasoshock #akutafdeling… | Lasse Paludan Bentsen
(English below)
En milepæl er nået i VASOSHOCK forsøget.
Vi har nu inkluderet patient nr. 80, hvilket er 50% af vejen til vores delmål i projektet og 25% af…
www.linkedin.com
March 18, 2025 at 11:31 AM
We just included our 80th patient (of 320) in #VASOSHOCK a multi-center RCT comparing noradrenaline to standard care (Where noradrenaline is not available as an ED intervention) in patients with hypotension and shock.
#emergencymedicine #criticalcare #research
#emergencymedicine #criticalcare #research
Reposted by Lasse Paludan Bentsen
Time to celebrate!
Lasse P Bentsen has reached the first 80 (out of 320) patients in his #VasoShock trial.
#VasoShock is an RCT comparing early noradrenalin in the ED in hypotensive patients vs. standard care.
Huge congratulations!
#emergencymedicine #research
www.linkedin.com/posts/lasse-...
Lasse P Bentsen has reached the first 80 (out of 320) patients in his #VasoShock trial.
#VasoShock is an RCT comparing early noradrenalin in the ED in hypotensive patients vs. standard care.
Huge congratulations!
#emergencymedicine #research
www.linkedin.com/posts/lasse-...
#fam #akutmedicin #emergencymedicine #vasoshock #akutafdeling… | Lasse Paludan Bentsen
(English below)
En milepæl er nået i VASOSHOCK forsøget.
Vi har nu inkluderet patient nr. 80, hvilket er 50% af vejen til vores delmål i projektet og 25% af…
www.linkedin.com
March 18, 2025 at 9:50 AM
Time to celebrate!
Lasse P Bentsen has reached the first 80 (out of 320) patients in his #VasoShock trial.
#VasoShock is an RCT comparing early noradrenalin in the ED in hypotensive patients vs. standard care.
Huge congratulations!
#emergencymedicine #research
www.linkedin.com/posts/lasse-...
Lasse P Bentsen has reached the first 80 (out of 320) patients in his #VasoShock trial.
#VasoShock is an RCT comparing early noradrenalin in the ED in hypotensive patients vs. standard care.
Huge congratulations!
#emergencymedicine #research
www.linkedin.com/posts/lasse-...